UK @ AdvaMed 2012
Sunday, September 30, 2012 at 7:00 PM - Thursday, October 4, 2012 at 4:00 PM (EDT)
Boston, United States
UK Trade & Investment invite you to Boston this Autumn 2012 for a unique opportunity to scope and access the US healthcare market. Learn from your peers, make new connections, and advance your global growth strategy.
AdvaMed 2012: The MedTech Conference, the premier medical device and diagnostics industry event, is an annual international conference hosted by the Advanced Medical Technology Association (AdvaMed). For the first time ever it will be held in Boston, one of the largest and most vibrant medtech clusters in the world. The conference attracts more than 1,900 executives from many of the world’s largest and best known medical device and diagnostic companies.
AdvaMed 2012 boasts hundreds of business executives with responsibilities ranging from regulatory and reimbursement affairs, to business development, legal/IP, and quality; as well as policy-makers, investors, distributors, national and trade media, and other crucial industry service providers from the US and abroad. Educational panels and keynotes featuring thought-leaders will discuss the issues and policies that are important to the medtech industry.
This year includes an expanded diagnostic track, AdvaMedDx, which will provide insights into the policy and business environment facing the rapidly evolving and growing diagnostics industry.
Join a group of innovative UK device and diagnostics companies on a healthcare market access mission to Advamed 2012. Led by UKTI, with the support of ABHI, Medilink UK, BIVDA, One Nucleus and the Devolved Administrations, we are recruiting companies with cutting edge medical technologies for four days of activities and interaction with key healthcare companies, investors, and market specialists at the leading medical technology, business development, policy forum, and capital formation event in North America.
Mission activities will include:
Participation in a pre-conference UKTI briefing session
Tailored programme for British delegates providing information on US market access, regulatory and reimbursement strategy, doing business with strategics, distribution and hospital procurement
One-to-one meetings with industry subject matter experts
Invitation to an exclusive networking dinner at the Massachusetts State House
Discounted conference registration rate of $895
Company listing in UK @ AdvaMed brochure
Opportunity to display your company’s literature on UKTI exhibit stand
Local site visit programme organized by AdvaMed for international delegations (optional – held on Thursday, 4th October, details to be announced shortly)
The UK delegation will have an unprecedented opportunity to meet with Lord Howe, Sir Bruce Keogh, Sir Michael Rawlins, and a broader group of officials from the Department of Health, NICE, MHRA, and CPRD at the UKTI stand on Tuesday, 2nd October.
To view information on the AdvaMed Conference go to http://advamed2012.com/
TERMS AND CONDITIONS
To be eligible for the mission companies must be UK based and actively developing, manufacturing, or selling a product/technology/service in the healthcare market.
Companies based in England must fill out the Advamed 2012 Application form linked above.
Companies based in Scotland, Wales, or Northern Ireland must email the respective organisations below and join the mission through them:
If you are selected to participate in this mission, you will be required to make payment of a £780 mission fee though UKTI’s Overseas Market Introduction Service (OMIS). This fee provides for overall mission programme and outlined activities. UKTI will provide you with your OMIS login details and instructions on how to make payment though the system.
Costs associated with travel, accommodations, and conference registration are NOT included in this fee, and delegates are responsible for these arrangements separately. The discounted conference registration code will be provided to register for the AdvaMed Conference. Discounted hotel accommodations are available through the Advamed website. Please do not book any travel until we confirm your place.
Application to attend this mission does not guarantee selection. Selection to attend is a competitive review process.
Deadline to apply is 1st August 2012, and applications will be considered on a rolling basis.
All applicants will be notified by 3rd August 2012 whether or not they have been selected to participate in this mission.
If you are selected to participate in this mission, you must make payment via the OMIS system by 1st September 2012 to guarantee your space in the mission.
The UK @ AdvaMed 2012 delegation is one of two government backed healthtech trade missions travelling to Boston to coincide with the AdvaMed conference. If you are an early stage, entreprenuer-led company with transformative technologies in development you may be interested in attending the Future Health Mission which is focused on engaging with innovation partners and investigating future US market opportunities, as well as finding potential investors and supply chain partners. www.futurehealthmission.com
When & Where
UK Trade & Investment and Scottish Development International
UK Trade & Investment (UKTI) is the British Government organization that helps overseas companies bring high-quality investment to the UK -- widely acknowledged as Europe’s best place from which to succeed in global business. We provide free and confidential support and advice to investors at all stages of business decision-making. Our network of international specialists in the UK and diplomatic posts around the world leverage expertise and contacts that help your international growth strategy succeed. UKTI can help you make sound investment decisions, based on our commercial expertise, and unrivalled local access and knowledge. We offer sector introductions, bespoke market reports, regional analysis, and central government access to help get your business off the ground.
Scottish Development International (SDI) is a government-funded organisation with a dedicated life sciences team which provides access to Scottish product/service companies, together with research and clinical expertise from Scottish Universities/Research Institutes in areas including Contract Research, Drug Discovery & Development, Medical Technologies, Regenerative Medicine & Stem Cells and Translational Medicine.